HEMOSTATIC SYSTEM DISORDERS IN PATIENTS WITH COXARTHROSIS OF III–IV STAGES AFTER TOTAL HIP ARTHROPLASTY (LITERATURE REVIEW)
DOI:
https://doi.org/10.15674/0030-598720251107-114Keywords:
Hemostasis, endoprosthetics, hip joint, thromboembolism, plasminogenAbstract
Objective. Тo analyze the current state of diagnosis and prevention of hemostatic disorders in patients with Kellgren-Lawrence grade III-IV coxarthrosis after total hip arthroplasty based on s cientific l iterature. M ethods. A search was performed in PubMed, Web of Science, Google Scholar and Scopus. Using MeSH and keywords such as: "inflammatory markers", "coxarthrosis", "thromboembolism", "tranexamic acid", "anticoagulants", "inflammation", "fibrinolysis", "D-dimer", "arthroplasty", "hypercoagulability", "plasminogen". Results. An important issue in the prevention of thromboembolic complications during total hip arthroplasty is to determine the dynamics of fibrinolysis disorders. Thus, it was found that hip arthroplasty is characterized by an increase in inflammatory markers in the blood and hemostatic disorders. Conclusions. In clinical orthopedics, after hip arthroplasty in patients with coxarthrosis of III-IV stages, complications often occur in the form of hemostatic disorders, which are accompanied by the development of deep vein thrombosis of the extremities, in severe cases — pulmonary embolism. These complications are monitored based on the results of determining the markers of the hemostatic system, which are examined before and after surgery. It has been proven that there are many different factors that affect the development of hemostatic disorders in the body. The age factor, as elderly patients have their own metabolic characteristics and altered rheological properties of blood. Increased body weight, in particular, obesity, is also an important factor that cannot be ignored in clinical practice. To date, clear clinical and laboratory criteria for assessing the hemostatic system and a list of biochemical markers of connective tissue to monitor the condition of patients before and after joint replacement in the context of modern anticoagulant regimens remain to be defined.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2025 Oleksandr Vysotskyi
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.
Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.
The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).
